PSTX - Poseida Therapeutics, Inc.
IEX Last Trade
9.41
0 0%
Share volume: 20,926
Last Updated: Fri 27 Dec 2024 08:30:26 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$9.41
0.00
0.00%
Summary score
17%
Profitability
8%
Dept financing
16%
Liquidity
64%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-23%
Return on assets
-10.44%
Return on sales
-693.24%
Return on invested capital
182.88%
Total debt ratio
50.82%
Debt ratio change over timeo
-0.65%
Current Ratio
5.23%
Quick Ratio
5.23%
Cash Position Ratio
4.97%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-24.78%
Return on assets
-10.18%
Return on sales
-179.37%
Return on invested capital
-535.25%
Total debt ratio
60.22%
Debt ratio change over timeo
-0.57%
Current Ratio
3.41%
Quick Ratio
3.41%
Cash Position Ratio
3.18%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-28.69%
Return on assets
-9.36%
Return on sales
-87.33%
Return on invested capital
62.38%
Total debt ratio
67.78%
Debt ratio change over time
-0.36%
Current Ratio
2.56%
Quick Ratio
2.56%
Cash Position Ratio
2.34%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-120.01%
Return on assets
-110.05%
Return on sales
4.93%
Return on invested capital
-44.01%
Total debt ratio
-65.48%
Debt ratio change over time
-0.65%
Current Ratio
2.54%
Quick Ratio
2.54%
Cash Position Ratio
2.39%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | PSTX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -23% | 13.79% | 34.47% | 7.43% |
| Return on assets | -10.44% | 2.76% | 3.15% | 5.62% |
| Return on sales | -693.24% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 182.88% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 40% | 60% | 58% |
| Total debt ratio | 50.82% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -0.65% | 308.97% | -6.99% | 1.18% |
| Dept financing | 14% | 50% | 25% | 7% |
| Current Ratio | 3.41% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 3.41% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 3.18% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 10% | 21% | 49% |
| Short-term ratios | PSTX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -24.78% | 13.77% | 13.25% | 3.8% |
| Return on assets | -10.18% | 2.43% | 1.89% | 3.09% |
| Return on sales | -179.37% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -535.25% | 2.14% | 3.39% | 9.18% |
| Profitability | 0% | 71% | 68% | 82% |
| Total debt ratio | 60.22% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -0.57% | 46.38% | -72.08% | 1.51% |
| Dept financing | 16% | 50% | 25% | 7% |
| Current Ratio | 3.41% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 3.41% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 3.18% | 0.36% | 1.28% | 2.93% |
| Liquididy | 59% | 11% | 30% | 73% |